Bioxytran, Inc.
BIXT
$0.02
$0.005.42%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.49M | -2.84M | -2.12M | -2.35M | -2.46M |
| Total Depreciation and Amortization | 14.80K | 9.20K | 9.00K | 9.00K | 6.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | 622.80K | 647.80K |
| Total Other Non-Cash Items | 1.34M | 1.15M | 785.30K | 341.60K | 433.40K |
| Change in Net Operating Assets | 1.27M | 1.09M | 809.60K | 969.70K | 933.20K |
| Cash from Operations | -866.90K | -590.30K | -519.00K | -409.90K | -441.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -26.50K | -29.80K | -20.60K | -26.50K | -35.60K |
| Cash from Investing | -26.50K | -29.80K | -20.60K | -26.50K | -35.60K |
| Total Debt Issued | 62.00K | 156.60K | 323.10K | 412.80K | 477.10K |
| Total Debt Repaid | -40.10K | -50.10K | -10.00K | -10.00K | -10.00K |
| Issuance of Common Stock | 630.00K | 584.70K | 439.00K | 13.40K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 415.60K | 387.50K | 292.20K | -- | -- |
| Cash from Financing | 1.07M | 1.08M | 1.04M | 416.10K | 467.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 174.20K | 458.70K | 504.80K | -20.10K | -10.30K |